Search Login Register

Pirenzepine Summary

Description: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Also Known As: Azupharma Brand of Pirenzepine Dihydrochloride; Boehringer Ingelheim Brand of Pirenzepine Dihydrochloride; Dolorgiet Brand of Pirenzepine Dihydrochloride; Gastrotsepin; Gastrozepin Show All >>

Networked: 484 relevant articles (70 outcomes, 103 trials/studies) for this Bio-Agent

Key Diseases for which Pirenzepine is Relevant

  1. Duodenal Ulcer (Curling's Ulcer) : 19 outcomes 38 studies in 108 results
  2. Ulcer : 10 outcomes 14 studies in 94 results
  3. Myopia : 10 outcomes 10 studies in 32 results
  4. Peptic Ulcer (Peptic Ulcers) : 7 outcomes 7 studies in 55 results
  5. Stomach Ulcer (Gastric Ulcer) : 5 outcomes 11 studies in 28 results
Show All >>

Drugs Related to Pirenzepine

  1. Cimetidine (Biomet)
  2. Sucralfate (Carafate)
  3. Ranitidine (Zantac)
  4. Atropine (Hyoscyamine)
  5. Antacids
  6. Famotidine (Pepcid)
  7. Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
  8. bismuth tripotassium dicitrate (bismuth subcitrate)
  9. Gallamine Triethiodide (Gallamine)
  10. Enprostil
Show All >>

Therapies Related to Pirenzepine

  1. Intensive Care (Surgical Intensive Care)
  2. Lenses
  3. Drug Therapy (Chemotherapy)
  4. Aftercare (After-Treatment)
  5. Topical Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.